Article · 30 Apr 2025
OtherPublished 13 Jul 2016
Everolimus for the treatment of advanced pancreatic neuroendocrine tumors
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Pancreatic neuroendocrine tumors (pNETs) account for 1–2% of all pancreatic tumors. Approximately two-thirds of patients have an advanced disease with metastases at diagnosis. Surgery is still the gold-standard treatment in most cases, while few medical options exist for inoperable tumors. A new potential therapeutic approach for advanced pNETs results from targeting intracellular molecular pathways. Rapalogs – rapamycin analogs including everolimus – target the mTOR signaling cascade, inhibit cell proliferation and evoke apoptosis. Recent Phase II and III clinical trials demonstrated that everolimus is effective in advanced pNETs as it increases progression-free survival of treated patients. Everolimus appears to be promising for advanced pNETs and is usually tolerated with mainly mild adverse events. Future studies will establish whether everolimus, alone or in combination with other compounds (e.g., new somatostatin analogs, cytotoxic agents and anti-angiogenetic drugs), will also prove to be a valid option for patients with other forms of advanced neuroendocrine tumors.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Investigation.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Investigation
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Paola Tomassetti”
- BylineArticles whose byline prints “Monica Cevenini”
- BylineArticles whose byline prints “Elena Guidetti”
- BylineArticles whose byline prints “Giulia Cacciari”
- BylineArticles whose byline prints “Maria Luigia Cipollini”
- BylineArticles whose byline prints “Elena Galassi”
- BylineArticles whose byline prints “Maria Camilla Fabbri”
- BylineArticles whose byline prints “Francesca Nori”